Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.97M Buy
28,345
+2,422
+9% +$863K 0.36% 36
2025
Q4
$8.48M Buy
25,923
+5,247
+25% +$1.66M 0.31% 42
2025
Q3
$5.83M Sell
20,676
-289
-1% -$83.8K 0.21% 67
2025
Q2
$5.85M Sell
20,965
-116
-0.6% -$32.9K 0.22% 63
2025
Q1
$6.57M Sell
21,081
-112
-0.5% -$33.1K 0.27% 55
2024
Q4
$5.52M Sell
21,193
-898
-4% -$266K 0.21% 63
2024
Q3
$7.12M Sell
22,091
-520
-2% -$170K 0.27% 49
2024
Q2
$7.06M Buy
22,611
+11,906
+111% +$3.5M 0.28% 48
2024
Q1
$3.04M Sell
10,705
-482
-4% -$141K 0.12% 95
2023
Q4
$3.22M Buy
+11,187
New +$3.05M 0.13% 93

Other funds holding AMGN

GLOBALT Investments's AMGN Position: Q1 2026 in Review

GLOBALT Investments increased its Amgen (AMGN) stake by 9.3% in Q1 2026, buying an estimated $863K and bringing the position to 28,345 shares worth $9.97M. The position accounts for 0.36% of the portfolio, ranked #36.

GLOBALT Investments first reported a position in AMGN in Q4 2023 and has held it in 10 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • GLOBALT Investments held 28,345 shares of Amgen worth $9.97M as of Q1 2026.
  • GLOBALT Investments bought 2,422 Amgen shares in Q1 2026, an estimated $863K.
  • Amgen made up 0.36% of GLOBALT Investments's portfolio in Q1 2026, its #36 holding.
  • GLOBALT Investments first reported a position in Amgen in Q4 2023 and has held it in 10 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on GLOBALT Investments's 13F filing for Q1 2026, filed 15 May 2026.